CBD AND SEX LIFE
Sex life is an important part of human well-being and
pleasure. Many people experience difficulties or problems that affect their sex
life, and this can have a negative effect on their psychological and physical
well-being. Recently, there has been increased interest in the use of CBD
(cannabidiol) oil to support and improve sexual function. In this article, we
will look at the positive benefits reported in research studies regarding the
use of CBD oil for sex life in general.
Human Well-being and
Sexual Function: Sexual function is linked to many factors, including
normal blood circulation, immune function, psychological well-being and hormone
balance. Disturbances in these factors can lead to sexual function problems,
such as erectile dysfunction, lack of desire, and orgasmic disorders.
The Benefits of CBD
Oil for Sex Life:
Anxiety Reduction:
Studies have shown that CBD oil can help reduce anxiety, which can be a major
factor affecting sexual performance and enjoyment.
Anti-inflammatory
properties: The anti-inflammatory properties of CBD oil can help reduce
inflammation in the body, which may contribute to the discharge and better
functioning of the sexual organs.
Enhance blood
circulation: Some studies have shown that CBD oil can improve blood
circulation, thereby promoting healthy blood flow to the genitals and helping
to achieve and maintain an erection.
Pain relief: CBD
oil can have analgesic properties and help relieve pain associated with sexual
disorders, such as endometriosis or pain during intercourse.
Enhance sensation and
sensitivity: Some studies have claimed that CBD oil can increase sensation
and sensitivity during intercourse, offering an enhanced sexual experience.
Conclusions:
Despite the limited number of studies that have investigated the association
between CBD oil and sexual function, early research and experimental studies
provide encouraging results. CBD oil can help relieve anxiety, improve blood
circulation, relieve pain, and increase sensation and sensitivity.
Sources:
Blessing, E. M., Steenkamp, M. M., Manzanares, J., &
Marmar, C. R. (2015). Cannabidiol as a Potential Treatment for Anxiety
Disorders. Neurotherapeutics, 12(4), 825–836.
Burstein, S. (2015). Cannabidiol (CBD) and its analogs: A
review of their effects on inflammation. Bioorganic & Medicinal Chemistry,
23(7), 1377–1385.
Kozela, E., Lev, N., Kaushansky, N., Eilam, R., Rimmerman,
N., Levy, R., Ben-Nun, A., & Juknat, A. (2016). Cannabidiol inhibits
pathogenic T cells, decreases spinal microglial activation and ameliorates
multiple sclerosis-like disease in C57BL/6 mice. British Journal of Pharmacology,
173(25), 1792–1807.
Russo, E. B. (2008). Cannabinoids in the management of
difficult to treat pain. Therapeutics and Clinical Risk Management, 4(1),
245–259.
Valjent, E., Mitchell, J. M., Besson, M. J., & Caboche,
J. (2002). Δ9-tetrahydrocannabinol-induced MAPK/ERK and Elk-1 activation in
vivo depends on dopaminergic transmission. European Journal of Neuroscience,
16(10), 1969–1972.
Leave a Comment